Inventor · disambiguated record
Jérôme Emile Georges Guillemont
Also filed as: GUILLEMONT JEROME · GUILLEMONT JEROME E G · GUILLEMONT JEROME EMILE GEORGE · GUILLEMONT JEROME EMILE GEORGES
106 granted patents·30 pending applications·451 citations·filing 1990–2023
99Inventor score
Files withJANSSEN PHARMACEUTICA NV30JANSSEN SCIENCES IRELAND UNLIMITED CO27JANSSEN SCIENCES IRELAND UC24GUILLEMONT JEROME EMILE GEORGES14GUILLEMONT JERÔME EMILE GEORGES7
Top patents by PatentIndex Score
136 records- 0196US7531548B2HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidinesTIBOTEC PHARM LTD·Filed 2005·Granted May 12, 2009·62 cites·18 claims
- 0293US7361657B2Respiratory syncytial virus replication inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Apr 22, 2008·22 cites·6 claims
- 0392US10611732B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Apr 7, 2020·3 cites·7 claims
- 0492US10611769B2RSV antiviral pyrazolo- and triazolo-pyrimidine compoundsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Apr 7, 2020·6 cites·16 claims
- 0592US10208048B2RSV antiviral pyrazolo- and triazolo-pyrimidine compoundsJANSSEN SCIENCES IRELAND UC·Filed 2016·Granted Feb 19, 2019·7 cites·20 claims
- 0692US8153640B2HIV inhibiting bicyclic pyrimdine derivativesGUILLEMONT JEROME EMILE GEORGES·Filed 2005·Granted Apr 10, 2012·13 cites·18 claims
- 0791US11866419B2Antibacterial compoundsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Granted Jan 9, 2024·1 cites·18 claims
- 0891US7902225B2Mycobacterial inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Mar 8, 2011·17 cites·14 claims
- 0990US9932346B2Pyrrolopyrimidines for use in influenza virus infectionJANSSEN SCIENCES IRELAND UC·Filed 2015·Granted Apr 3, 2018·5 cites·19 claims
- 1089US8906923B2Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinonesGUILLEMONT JERÔME EMILE GEORGES·Filed 2012·Granted Dec 9, 2014·10 cites·12 claims
- 1189US7956063B2Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jun 7, 2011·8 cites·7 claims
- 1288US9598407B2Antibacterial piperidinyl substituted 3,4-dihydro-1H-[1,8]naphthyridinonesJANSSEN SCIENCES IRELAND UC·Filed 2015·Granted Mar 21, 2017·4 cites·5 claims
- 1388US8101629B2Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileGUILLEMONT JEROME EMILE GEORGES·Filed 2010·Granted Jan 24, 2012·8 cites·21 claims
- 1487US10364232B2Antibacterial compoundsJANSSEN SCIENCES IRELAND UC·Filed 2016·Granted Jul 30, 2019·3 cites·4 claims
- 1587US9617262B2Antibacterial cyclopental[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinonesJANSSEN SCIENCES IRELAND UC·Filed 2016·Granted Apr 11, 2017·4 cites·2 claims
- 1687US9416114B21,2,4-triazine derivatives for the treatment of viral infectionsCENTRE NAT DE LA RECH SCIENT (CNRS)·Filed 2013·Granted Aug 16, 2016·26 cites·7 claims
- 1787US9290493B2Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinonesJANSSEN SCIENCES IRELAND UC·Filed 2014·Granted Mar 22, 2016·6 cites·2 claims
- 1886US10072015B2HIV inhibiting bicyclic pyrimidine derivativesJANSSEN SCIENCES IRELAND UC·Filed 2017·Granted Sep 11, 2018·2 cites·9 claims
- 1986US8080551B2HIV inhibiting pyrimidines derivativesGUILLEMONT JEROME EMILE GEORGES·Filed 2006·Granted Dec 20, 2011·8 cites·39 claims
- 2086US8017606B2Quinoline derivatives as antibacterial agentsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Sep 13, 2011·14 cites·19 claims
- 2186US7638522B2Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Dec 29, 2009·10 cites·1 claims
- 2286US2024132470A1Antibacterial CompoundsJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Application pending·0 cites
- 2385US9884864B2Antibacterial cyclopenta[C]pyrrole substituted 3,4-Dihydro-1H-[1,8]naphthyridinonesJANSSEN SCIENCES IRELAND UC·Filed 2017·Granted Feb 6, 2018·3 cites·2 claims
- 2485US7928104B27-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitorsMABIRE DOMINIQUE JEAN-PIERRE·Filed 2004·Granted Apr 19, 2011·25 cites·12 claims
- 2585US7705148B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Apr 27, 2010·7 cites·9 claims
- 2685US7399856B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-2pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Jul 15, 2008·19 cites·12 claims
- 2784US8618100B2Compounds with antibacterial activity against ClostridiumGUILLEMONT JEROME EMILE GEORGES·Filed 2011·Granted Dec 31, 2013·9 cites·15 claims
- 2884US7563922B2Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrileJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 21, 2009·6 cites·6 claims
- 2984US7173034B2Respiratory syncytial virus replication inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 6, 2007·5 cites·14 claims
- 3083US11180472B2Antibacterial compoundsJANSSEN SCIENCES IRELAND UC·Filed 2020·Granted Nov 23, 2021·1 cites·14 claims
- 3183US10155759B2Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinonesJANSSEN SCIENCES IRELAND UC·Filed 2017·Granted Dec 18, 2018·2 cites·2 claims
- 3283US9981919B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 29, 2018·2 cites·7 claims
- 3383US8828982B2Pyrimidine derivatives for the prevention of HIV infectionHEERES JAN·Filed 2009·Granted Sep 9, 2014·5 cites·18 claims
- 3482US9133167B2Antibacterial quinoline derivativesJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Sep 15, 2015·3 cites·25 claims
- 3582US7790894B2Mycobacterial inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Sep 7, 2010·6 cites·18 claims
- 3682US7709498B2Quinoline derivatives as antibacterial agentsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted May 4, 2010·6 cites·35 claims
- 3781US10508097B2Antibacterial compounds and uses thereofGLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC·Filed 2017·Granted Dec 17, 2019·2 cites·24 claims
- 3881US8623872B2Quinazolinone derivatives as PARP inhibitorsGUILLEMONT JEROME EMILE GEORGES·Filed 2005·Granted Jan 7, 2014·3 cites·17 claims
- 3980US7879857B26-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 1, 2011·11 cites·10 claims
- 4079US9580392B2HIV replication inhibiting pyrimidinesJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 28, 2017·2 cites·8 claims
- 4179US7498343B2Mycobacterial inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Mar 3, 2009·19 cites·24 claims
- 4279US7442705B2HIV replication inhibiting pyrimidines and triazinesTIBOTEC PHARM LTD·Filed 2004·Granted Oct 28, 2008·12 cites·11 claims
- 4379US6924287B1Respiratory syncytial virus replication inhibitorsJANSSEN PHARMACATICA N V·Filed 2000·Granted Aug 2, 2005·13 cites·7 claims
- 4478US8415475B2Antibacterial quinoline derivativesGUILLEMONT JEROME EMILE GEORGES·Filed 2007·Granted Apr 9, 2013·4 cites·25 claims
- 4578US7173054B2Respiratory syncytial virus replication inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Feb 6, 2007·2 cites·9 claims
- 4677US10611755B2Aryl substituted pyrimidines for use in influenza virus infectionJANSSEN SCIENCES IRELAND UC·Filed 2017·Granted Apr 7, 2020·1 cites·8 claims
- 4777US9487518B2HIV inhibiting bicyclic pyrimidine derivativesGUILLEMONT JERÔME EMILE GEORGES·Filed 2012·Granted Nov 8, 2016·1 cites·4 claims
- 4875US11597704B22,4-diaminoquinazoline derivatives and medical uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Mar 7, 2023·1 cites·40 claims
- 4975US9428474B2Antibacterial compoundsJANSSEN SCIENCES IRELAND UC·Filed 2013·Granted Aug 30, 2016·2 cites·6 claims
- 5075US7071192B1Respiratory syncytial virus replication inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2000·Granted Jul 4, 2006·7 cites·16 claims
Showing the top 50 of 136 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →